Fifth Third Bancorp Ionis Pharmaceuticals Inc Transaction History
Fifth Third Bancorp
- $25.9 Billion
- Q1 2025
A detailed history of Fifth Third Bancorp transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Fifth Third Bancorp holds 9,989 shares of IONS stock, worth $296,673. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,989
Previous 9,531
4.81%
Holding current value
$296,673
Previous $333,000
9.61%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding IONS
# of Institutions
409Shares Held
132MCall Options Held
829KPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA16.5MShares$489 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$421 Million0.31% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$341 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$307 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$234 Million5.48% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.22B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...